PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: SEGMENTATION BY PRODUCT • Overview • Comparison by product • Oral medications • Topical medications • Parenteral medications • Other medications • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increasing prevalence of hormonal imbalance • Implementation of compounding policy priorities plan • Increase in number of overweight and obese people PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Fagron • B. Braun Melsungen • Fresenius • Wedgewood Pharmacy • Dougherty's Pharmacy • Village Compounding Pharmacy • Other prominent vendors PART 15: APPENDIX • List of abbreviations   Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 04: Market definition: Inclusions and exclusions checklist Exhibit 05: Market size 2017 Exhibit 06: Validation techniques employed for market sizing 2017 Exhibit 07: Global compounding pharmacy market 2017-2022 ($ billions) Exhibit 08: Global compounding pharmacy market: Year-over-year growth 2018-2022 (%) Exhibit 09: Five forces analysis 2017 Exhibit 10: Five forces analysis 2022 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition: Five forces 2017 Exhibit 17: Global compounding pharmacy market: Segmentation by product 2017-2022 (% share) Exhibit 18: Comparison by product Exhibit 19: Global compounding pharmacy market for oral medications 2017-2022 ($ billions) Exhibit 20: Global compounding pharmacy market for oral medications: Year-over-year growth 2018-2022 (%) Exhibit 21: Global compounding pharmacy market for topical medications 2017-2022 ($ billions) Exhibit 22: Global compounding pharmacy market for topical medications: Year-over-year growth 2018-2022 (%) Exhibit 23: Global compounding pharmacy market for parenteral medications 2017-2022 ($ billions) Exhibit 24: Global compounding pharmacy market for parenteral medications: Year-over-year growth 2018-2022 (%) Exhibit 25: Global compounding pharmacy market for other medications 2017-2022 ($ billions) Exhibit 26: Global compounding pharmacy market for other medications: Year-over-year growth 2018-2022 (%) Exhibit 27: Market opportunity by product Exhibit 28: Customer landscape Exhibit 29: Global compounding pharmacy market: Segmentation by geography 2017-2022 (% share) Exhibit 30: Regional comparison Exhibit 31: Compounding pharmacy market in Americas 2017-2022 ($ billions) Exhibit 32: Compounding pharmacy market in Americas: Year-over-year growth 2018-2022 (%) Exhibit 33: Top-three countries in Americas Exhibit 34: Compounding pharmacy market in EMEA 2017-2022 ($ billions) Exhibit 35: Compounding pharmacy market in EMEA: Year-over-year growth 2018-2022 (%) Exhibit 36: Top-three countries in EMEA Exhibit 37: Compounding pharmacy market in APAC 2017-2022 ($ billions) Exhibit 38: Compounding pharmacy market in APAC: Year-over-year growth 2018-2022 (%) Exhibit 39: Top-three countries in APAC Exhibit 40: Market opportunity Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Fagron: Overview Exhibit 47: Fagron: Business segments Exhibit 48: Fagron: Organizational developments Exhibit 49: Fagron: Geographic focus Exhibit 50: Fagron: Segment focus Exhibit 51: Fagron: Key offerings Exhibit 52: B. Braun Melsungen: Overview Exhibit 53: B. Braun Melsungen: Business segments Exhibit 54: B. Braun Melsungen: Organizational developments Exhibit 55: B. Braun Melsungen: Geographic focus Exhibit 56: B. Braun Melsungen: Segment focus Exhibit 57: B. Braun Melsungen: Key offerings Exhibit 58: Fresenius: Overview Exhibit 59: Fresenius: Business segments Exhibit 60: Fresenius: Organizational developments Exhibit 61: Fresenius: Geographic focus Exhibit 62: Fresenius: Segment focus Exhibit 63: Fresenius: Key offerings Exhibit 64: Wedgewood Pharmacy: Overview Exhibit 65: Wedgewood Pharmacy: Business segments Exhibit 66: Wedgewood Pharmacy: Organizational developments Exhibit 67: Wedgewood Pharmacy: Geographic focus Exhibit 68: Wedgewood pharmacy: Segment focus Exhibit 69: Wedgewood pharmacy: Key offerings Exhibit 70: Dougherty' Pharmacy: Overview Exhibit 71: Dougherty's Pharmacy: Business segments Exhibit 72: Dougherty's Pharmacy: Organizational developments Exhibit 73: Dougherty's Pharmacy: Geographic focus Exhibit 74: Dougherty's Pharmacy: Segment focus Exhibit 75: Dougherty's Pharmacy: Key offerings Exhibit 76: Village Compounding Pharmacy: Overview Exhibit 77: Village Compounding Pharmacy: Business segments Exhibit 78: Village Compounding Pharmacy: Organizational developments Exhibit 79: Village Compounding Pharmacy: Geographic focus Exhibit 80: Village Compounding Pharmacy: Segment focus Exhibit 81: Village Compounding Pharmacy: Key offerings

Fagron B. Braun Melsungen Fresenius Wedgewood Pharmacy Dougherty's Pharmacy Village Compounding Pharmacy Other prominent vendors